NCLAT: Consideration of Debt Restructuring by Lenders Doesn’t Bar Member from Initiating Proceedings  ||  Delhi High Court: In Matters of Medical Evaluation, Courts Should Exercise Restraint  ||  Delhi HC: Any Person in India Has Right to Legally Import Goods from Abroad and Sell the Same  ||  Delhi HC: Waiver to Section 12(5) of Arbitration Act to be Given Once Tribunal is Constituted  ||  Supreme Court Has Asked States to Regularise Existing Court Managers  ||  SC: Union & States to Create Special POSCO Courts on Top Priority  ||  SC Upholds Authority of CERC to Award Compensation for Delays  ||  SC: Arbitral Tribunal Has Discretion to Include in Sum Awarded, Interest at Rate as it Deems Reasonab  ||  SC: Cannot Use Article 142 to Frame Guidelines on Judicial Recusal  ||  SC: Satisfaction Recorder in One EP Won’t Affect Subsequent EPs for Future Breaches    

Delhi HC Restrains Glenmark Pharmaceuticals from Manufacturing, Selling Zita and Zita-Met - (07 Oct 2015)

Delhi High Court has restrained Glenmark Pharmaceuticals, an Indian firm, from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company Merck Sharp and Dohme.

Tags : DELHI HIGH COURT  GLENMARK PHARMACEUTICALS   MERCK SHARP AND DOHME   PATENT  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved